Background: Eosinophil count predicts outcome following myocardial infarction (MI) and eosinophils regulate tissue repair and regeneration in extra-cardiac settings.
HIGHLIGHTS
A drop in eosinophil blood count is associated with recruitment of eosinophils to the heart during repair following clinical and experimental myocardial infarction.
Genetic & pharmacological eosinophil depletion leads to increased adverse remodelling in experimental MI.
Eosinophils are required for aquisition of an anti-inflammatory macrophage phenotype and a shift to resolution of inflammation during infarct repair.
Interleukin-4 therapy is able to rescue the adverse remodelling phenotype in conditions of eosinophil deficiency.
List of abbreviations:
BMD: bone marrow-derived ELISA Enzyme linked immunoabsorbent assay hi: high IL: interleukin int: intermediate ip: intra-peritoneal MI: myocardial infarction lo: low STEMI: ST-segment elevation myocardial infarction WT: wild type
INTRODUCTION
Myocardial infarction (MI) occurs most commonly following acute thrombotic occlusion of a coronary artery, and triggers an acute inflammatory response. Within hours, neutrophils are recruited to the infarcted myocardium followed by infiltration of pro-inflammatory monocytes. 1 Acquisition of a pro-resolution proliferative macrophage phenotype is critical to successful infarct repair. 2 Failure to expand the number of CD206 + pro-resolution macrophages following MI is associated with increased cardiac rupture and adverse cardiac remodelling due to disrupted collagen fibril formation during infarct healing. 2 Interventions that polarize macrophages towards this phenotype, including interleukin-4 (IL-4), 2,3 improve infarct healing, but the endogenous mechanisms that regulate repair are not well understood.
Macrophage phenotype can be determined by environmental factors and importantly by cells of the innate and adaptive immune system, including eosinophils. Tissue eosinophilia is commonly associated with helminth infection, allergy and gastrointestinal disorders. In these settings, eosinophils are effector cells with pro-inflammatory and destructive capabilities through the secretion of cytotoxic granules, cationic proteins and proteolytic enzymes. 4 However, eosinophils also express a number of immuno-modulatory cytokines and lipid mediators implicated in the resolution of inflammation. 4 Previous studies have linked peripheral blood eosinophil count post-MI to short-term risk of mortality in low-intermediate risk patients 5 and high risk patients 6, 7 following myocardial infarction. However, whether eosinophils have any role in repair of the adult mammalian heart is so far unknown.
The primary goal of the present study was to address the role of eosinophils in repair of the heart following MI in the setting of patients with acute ST-segment elevation MI (STEMI) and in an experimental model of MI in mice with genetic (ΔdblGATA 8 ) or pharmacologic depletion of eosinophils.
METHODS

Patient selection with ST-segment elevation MI
All patients included in the STEMI registry were ≥ 18 years old, had chest pain of <12 hours duration, and persistent ST-segment elevation in at least two contiguous leads of the electrocardiogram. 9 Patients with a history of stable angina undergoing elective percutaneous coronary intervention were used as the control group. This study was reviewed and approved by the Essex Cardiothoracic Centre Clinical Governance body.
Animal experiments
12 to 14-week-old WT male BALB/c mice and C57Bl/6 mice were purchased from Harlan Laboratories (UK). Δ dblGATA mice on a BALB/c background 8, 10 were bred and maintained at the University of Edinburgh. All animal experiments were approved by the University of Edinburgh Animal Welfare and Ethical Review Board & the UK Home Office.
Infarct model
MI was induced by permanent ligation of the left coronary artery in isofluorane anaesthetized mice as previously described. 11 24h after surgery, a tail blood sample was collected for assay of troponin I (Life Diagnostics High Sensitivity Mouse Cardiac Troponin-I ELISA kit) to assess the extent of myocardial injury.
Anti-Siglec-F antiserum depletion of eosinophils
In the eosinophil depletion study, C57BL/6 mice received 100 μ L of either sheep anti-Siglec-F polyclonal antiserum or sheep pre-immune serum (both gifted by Professor Paul Crocker, University of Dundee) via intra-peritoneal injection at 1 day before and 3 days after MI.
Rescue experiments in
Δ dblGATA mice
Bone marrow-derived eosinophils were adoptively transferred by intra-peritoneal injection into Δ dblGATA mice at 1 day before and 3 days after MI. Purity of greater than 90% for eosinophils was confirmed prior to intra-peritoneal injection by flow cytometric analysis. 
Cardiac imaging
Left ventricular structure and function was assessed using high-resolution ultrasound (VisualSonics Vevo 770, Toronto, Canada), under light isoflurane anaesthesia, ensuring that the heart rate was maintained >500 beats/min.
Histopathology
Eosinophils were detected in samples of paraffin embedded infarcted human myocardium, obtained from the Edinburgh Brain & Tissue Bank (Online Table 2 ), using eosinophil peroxidase antibody (supplied by Elizabeth Jacobsen, Mayo Clinic, Scottsdale, Arizona).
Paraffin embedded mouse heart sections were stained with Masson's trichrome (infarct size) and picrosirius red (polarized light to collagen fibre status using polarizesd light).
Angiogenesis was determined by detection of CD31 immunopositive vessels (rabbit antimouse CD31, 1:50; Abcam).
Transmission Electron Microscopy
Mouse hearts were fixed in 1% Osmium Tetroxide in 0.1M Sodium Cacodylate X3) and embedded in TAAB 812 resin. Ultrathin sections, 60nm thick were stained in Uranyl Acetate and Lead Citrate then viewed in a JEOL JEM-1400 Plus TEM. Eosinophils were identified by their typical morphology with crystalloid granules.
Flow cytometry
Immunofluorescence staining was performed on tail blood samples and single cell suspensions from heart digests, spleens and peritoneal cells. Flow cytometric analysis was performed on an LSR II instrument (BD Biosciences) and analyzed using FlowJo software (Tree Star). Infarct zone CD45 + CD11b + Ly6G -F4/80 + macrophages were sorted by FACS using a FACS ARIA II flow cytometer (BD Biosciences). Results for the heart digests are expressed as cell number per infarct zone or remote zone, and total counts were calculated for spleens and the peripheral blood.
RNA extraction and real-time quantitative PCR
RNA was extracted from infarct zone tissue (RNeasy® Mini Kit, QIAGEN) and reverse transcribed to cDNA with the QuantiTect Reverse Transcription Kit. Real-time quantitative PCR was performed using TAQman® gene expression assays (Online Table 8 ). mRNA expression levels were normalized for Rpl32 (house keeping gene) expression and are presented as fold changes. Genes were selected based on prior microarray data from the lab (unpublished) that identified them as being significantly modified during the early stages of scar formation, between 3 and 7 days following MI. Left ventricular infarct zone tissue was collected 4 days after induction of MI and snap frozen. Tissue cytokines in the heart protein extracts were assayed using the mouse Th2
Tissue Cytokine Assay
Panel LEGENDplex assay (BioLegend), according to the manufactures instructions.
Statistics
Continuous variables are expressed as mean ± standard error of mean. Continuous variables with a normal distribution were analysed using Student t-test, and variables with a nonnormal distribution were analysed using Wilcoxon rank sum test. Two-sided p<0.05 was considered statistically significant. All statistical analyses were performed with SPSS 21.0 statistical software package (SPSS Inc, Chicago, IL).
RESULTS
Eosinophils are depleted from the blood and accumulate in the myocardium of patients after acute MI
In 732 patients presenting with STEMI (Online Table 1 ), blood eosinophil counts declined over the first 7-9 hours after the onset of chest pain and were suppressed compared to patients with stable angina (Figure 1a , p<0.01). Peripheral blood neutrophil count in STEMI patients remained elevated at a similar level following the onset of chest pain (Figure 1a , inset), while there continued to be a decline in eosinophil count over the same time period. Histological staining of three human post-mortem hearts, collected from patients who died within 24
hours of MI (Online Table 2 ), revealed the presence of eosinophil peroxidase immunopositive eosinophils within the infarct area, consistent with eosinophils recruitment to the heart in humans during the acute inflammatory phase following MI ( Figure 1b ).
Eosinophils are activated following experimental MI and accumulate in the infarcted left ventricle
To permit further interrogation of the role of eosinophils in the heart following MI, eosinophil numbers in the blood and heart were also investigated in an experimental mouse model of MI following coronary artery ligation. Flow cytometric evaluation of Siglec-F + eosinophils in blood and single cell digests of left ventricle (Figure 2a ) revealed that, in parallel with clinical observations, there was a peripheral blood eosinopenia after experimental MI (p=0.003; Figure 2b ). In keeping with previous studies, 12 Siglec-F + Ly6G int eosinophils were rarely found in uninjured hearts ( Figure 2c ). However, eosinophils were recruited to the heart from Day 1 post-MI, and particularly to the infarct zone, where their numbers peaked at Day 4 post-MI, during infarct repair ( Figure 2c ). The presense of eosinophils in tissue at day 4 was confirmed by their characteristic morphology on electron microscopy, with crystalloid containing granules in the spleen (Figure 2d ) and in the infarcted heart (Figure 2e ). In the infarct, variable granule morphology is consistent with eosinophil activation (Figure 2e , inset). Activation of recruited eosinophils was confirmed by flow cytometry that showed a higher intensity of Siglec-F expression on cells infiltrating the inflamed myocardium relative to naïve eosinophils residing in splenic lymphoid tissue
Infarct expansion and detrimental post-MI remodelling are enhanced following genetic depletion of eosinophils
To investigate the role of eosinophils recruited to the heart following injury, MI was induced in Δ dblGATA mice with genetic deficiency of eosinophils 8 In keeping with previous findings, 8 analysis of peripheral blood showed no significant differences between WT BALB/c and Δ dblGATA mice with respect to white blood cell counts at baseline (Online Table 3 ). Following the induction of MI, highresolution ultrasound showed that hearts from hours post-MI (Online Table 5 ). High-resolution ultrasound showed that hearts from anti-Siglec-F antiserum treated mice were more dilated ( Figure 4c ) and had greater impairment of left ventricular function than pre-immune serum treated mice (Figure 4d , Online Table 5 ).
Thus, pharmacological depletion of eosinophils in C57BL/6 mice confirmed the adverse cardiac remodelling phenotype associated with eosinophil depletion, further supporting a role for eosinophils in post-MI remodelling.
Eosinophils support an anti-inflammatory environment in the infarct zone
Anti-inflammatory Th2-type cytokines have a key role in the resolution of inflammation and are elevated in the infarct zone at Day 4 post-MI. 14 As eosinophils are known to support a type 2 immune environment during tissue repair and regeneration we next aimed to investigate the influence of eosinophil depletion on type 2 immune mediator availability in the infarct. In keeping with an anti-inflammatory role for eosinophils ELISA showed that the infarct tissue of 
Delayed acquisition of a pro-repair macrophage phenotype in eosinophil deficient myocardium is rescued by eosinophil replacement
Resolution of inflammation following MI occurs with a transition towards an antiinflammatory macrophage phenotype that is essential for repair and prevention of adverse cardiac remodelling. 2 CD206 expression is typically increased on these alternatively activated anti-inflammatory macrophages. 2 The next aim was therefore to investigate whether eosinophils were required for acquisition of a CD206 + anti-inflammatory macrophage phenotype following MI. CD206 was present on nearly 80% of macrophages in naïve hearts Table 7) .
DISCUSSION
Blood eosinophil count is reduced in the acute period following MI and we have previously shown that low peripheral blood eosinophil count predicts adverse outcome 5 . Analysis of human myocardium collected post-mortem following MI identified eosinophils, suggesting that they are recruited to the site of injury, consistent with previous identification of eosinophils in post-mortem myocardium collected following MI. 15 
Eosinophils are recruited to the heart and activated following experimental MI
In the mouse model, eosinophil numbers in the peripheral blood also declined after MI and this was associated with accumulation of eosinophils in the myocardium that began within 24
hours and continued to increase to a peak at 4 days after MI. The temporal mismatch between the decline of eosinophil numbers in the blood and accumulation in the tissue indicates a more complex regulation of peripheral blood eosinophils than can be accounted for simply by recruitment to tissue. Inflammatory cytokines produced by activated innate immune cells 16 and stress responses, mediated by adrenal corticosteroids, 17 can lead to eosinophil apoptosis and contribute to a decline in peripheral blood eosinophil count. Clarifying how the inflammatory environment following MI influences eosinophil survival during the period of eosinophil recruitment to the infarct zone will in future provide clues to better understand the association of peripheral blood eosinophil count with outcome in MI patients. [5] [6] [7] Recruitment of eosinophils to the repairing mouse myocardium, reproducing the clinical observation, is consistent with an active role for eosinophils following MI. This is further supported by the observation that on becoming resident in the infarcted heart, alteration of granule morphology 4,13 is accompaied by increased expression of Siglec-F, indicating a switch from a homeostatic to an activated phenotype. 13, 18 Eosinophil deplation results in adverse remodelling associated with impaired scar formation A functional role for eosinophils was confirmed in vivo in eosinophil-deficient Δ dblGATA mice, 8 and also in mice with antibody-mediated eosinophil depletion with anti-Siglec-F antiserum. 13 Both models of eosinophil depletion were accompanied by an increase in adverse structural and functional remodelling, indicating that eosinophils have a key positive impact on myocardial repair and remodelling following their recruitment from the blood.
Adverse remodelling was accompanied by an increase in infarct size in the myocardium of Δ dblGATA mice relative to WT, despite no difference in the initial ischaemia-induced injury.
Angiogenesis was unchanged in eosinophil deficient mice suggesting that infarct expansion did not occur due to lack of blood supply on the infarct border. Formation of a stable collagen scar is key for determination of wall stress, infarct expansion and subsequent ventricular remodelling following MI. Investigation of the infarct scar using birefringence microscopy revealed modification of collagen fibril formation in eosinophil deficient mice. Eosinophil depletion also resulted in increased infarct zone expression of plod2, encoding lysyl hydroxylases 2 (LH2), and also tgfb3, encoding Transforming Growth Factor beta 3 (TGFβ 3) which upregulates plod2 expression in fibroblasts. 19 Increased plod2 expression leads to increased post-translational collagen cross-linking, resulting in reduced tensile strength. [20] [21] [22] The detrimental effects of increased collagen cross-linking have been identified in the weakened aortic wall present in Marfan syndrome and abdominal aortic aneurysms. 22 Disrupted post-translational collagen processing in the infarct zone may therefore underlie infarct expansion and ventricular dilatation observed following MI in the absence of eosinophils.
Eosinophils are required to promote resolution of inflammation during post-infarct repair
Inflammation is essential for infarct repair; but when excessive or prolonged is associated with adverse cardiac remodelling. 23 In other settings eosinophil-derived pro-resolving lipid mediators can reduce the numbers of neutrophils in inflamed tissue, 3 healing phenotype. 25 Previous experiments have demonstrated the importance of this phenotype during post-MI repair 2 and the ability of therapeutic IL-4 to enhance accumulation of CD206 + 'wound healing' macrophages and prevent detrimental remodelling, at least when administered immediately after injury. 3 Eosinophils are a key source of IL-4 in a number of physiological processes, including non-cardiac tissue repair and regeneration. 18, 26, 27 Experiments in eosinophil-deficient mice showed IL-4 availability in the infarct was significantly reduced at Day 4 following MI, the time point at which eosinophil recruitment to the myocardium peaks, and also a key time-point for transition of macrophages from an inflammatory to a repair phenotype. 28 We therefore investigated the potential for IL-4 to rescue detrimental post-MI remodelling in eosinophil-deficient mice. Interestingly, administration of IL-4 complex 24 hours after MI, when eosinophil recruitment to the myocardium is already significantly increased, had no influence on post-MI remodelling in eosinophil-replete mice. This is consistent with the previous studies that showed therapeutic benefit of IL-4 only when given prior to, 2 or immediately after MI. 3 However, although IL-4
is only one of several mediators released by eosinophils with the potential to modify infarct repair, IL-4 complex administration was effective in reversing adverse cardiac remodelling observed in eosinophil-deficient mice. 1
In summary, this study identifies eosinophils as key effector cells of the type 2 innate immune response required for post-MI cardiac repair and prevention of adverse remodelling.
IL-4 therapy, proposed as a means to improve outcomes post-MI, 3 was effective in reversing detrimental outcomes in the setting of eosinophil deficiency in experimental MI. The use of biomarkers such as a persistently low peripheral blood eosinophil count post-MI may therefore provide a means to direct IL-4 therapy to patients who might gain the most benefit from it.
Competency in medical knowledge:
The resolution of inflammation is one of the central features of successful infarct healing following myocardial infarction. This process is modulated by a number of cellular and molecular mediators including eosinophils, likely through the provision of anti-inflammatory mediators, like IL-4.
Translational Outlook:
Further studies are needed to evaluate prospectively the prognostic predictive value of a low peripheral blood eosinophil count and the potential therapeutic efficacy of IL-4 in preventing adverse cardiac remodelling in patients following myocardial infarction. Chitinase-like 3 Chil3 Mm00657889_mH
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